The EMA, based on the opinion of the Committee for Medicinal Products for Veterinary Use, has recommended that the establishment of an MRL for ovotransferrin in chicken is not necessary for the protection of human health.
Recital 5, Regulation (EU) 2019/238
In forcesince 8 Feb 2019